About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Mylan Arbitration Hearing Concluded
November 9, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Entitlement Offer Raises Over AUD3M
Next Post
Phosphagenics Provides Update on TPM Propofol Development Program
Related Posts
Receipt of R&D Tax Incentive
March 1, 2017
Phosphagenics Announces Transition of Chairman of Board
April 21, 2017
Extension of Closing Date of Entitlement Offer
October 10, 2017